2 hrs ago | Newsday
Patient urges hepatitis inquiry
A Hull man with haemophilia is calling for an inquiry into how NHS patients were infected by contaminated blood during the 1970s and 80s.
4 hrs ago | Scotsman.com
New Hep C drugs to be given to Lothian patients
HEPATITIS C patients across the Lothians will be among the first to be given the option of two revolutionary treatments.
8 hrs ago | Black Enterprise
Today Marks the 12th Annual National Black HIV/AIDS Awareness Day
"On this National Black HIV/AIDS Awareness Day, we have greater opportunity than ever before to reverse the HIV epidemic in Black America and the nation as a whole," said Dr.
Amateur tattoos carry hepatitis C risk: Study
If you're planning on getting a tattoo, make sure it's from a professional and not a friend because ink work by amateurs may carry a risk of Hepatitis C, according to a new report.
Administration of Meningococcal Vaccine with Other Routine Infant Vaccines Appears Effective
Newswise - CHICAGO - Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against meningococcal strains and produced minimal interference with the response to the routine vaccinations, according to a study in ... (more)
Parents, make sure your kids s...
Parents need to make sure their kids shots are up to date soon. School exclusion day is February 15th in Oregon.
Closer Look: BioLineRx Snags Another Hep-C License Agreement
The shares of thinly traded BioLineRx soared as high as $5.86 following early Monday morning news that the firm had signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C. The stock was not able to hold on to the gains.
Biotech Stock Alert; Aethlon Medical (OTC: AEMD) to Present Hepatitis ...
Aethlon Medical, Inc. , the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that a presentation of the Aethlon Hemopurifier to treat Hepatitis C virus and other infectious disease conditions will occur at the upcoming 32nd Annual Dialysis ... (more)
Increased Risk Of Fatal Side Effects From 3 'Targeted' Cancer Drugs
Main Category: Cancer / Oncology Also Included In: Liver Disease / Hepatitis ; Urology / Nephrology Article Date: 07 Feb 2012 - 1:00 PST Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute.
New BHIVA guidelines recommend discussion with all patients on...
The British HIV Association today recommends that doctors should discuss the evidence for the effectiveness of antiretroviral treatment as prevention with all patients with HIV, and that it should be offered those who want to protect their partners from the risk of HIV infection - even if they have no immediate clinical need for treatment ... (more)
Third main cause of death in the country
Dr Mohamed al-Thani is seen with Hamad Medical Corporations Tertiary Hospitals Group chief Astley at a news conference yesterday Cancer has been identified as the third main cause of death in Qatar, accounting for 12% of total deaths, with 23.8% females and 8.7% males dying of the disease.
The markets jumped 158 points on Friday, or 1.2%, so stocks that went down by even larger percentages are pretty big deals .
Peptide inhibits replication of hepatitis C virus
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks the viral replication that can lead to liver cancer and cirrhosis.
BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment
BioLineRx   , a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C . The agreement includes upfront license fees, milestones and royalties payable to both companies, ... (more)
Coffee Consumption Reduces Fibrosis Risk In Those With Fatty Liver Disease
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease.
High Frequency of CD4+CXCR5+ TFH Cells in Patients with Immune-Active Chronic Hepatitis B
This study examined whether the frequency of CD4+CXCR5+ TFH cells could be associated with active immunity in chronic hepatitis B patients.
Nail salon nightmare: Hepatitis B from mani-pedis
Now a new study shows customers in nail salons could be putting themselves at risk for the deadly disease.
Liver resection for hepatocellular carcinoma in non-cirrhotic liver...
Between June 1998 and September 2003, 33 patients without viral hepatitis underwent resection for HCC in a non-cirrhotic, non-fibrotic liver.
HIV in Mendocino County: Only one or two new local cases each year
Mendocino County sees one or two new diagnoses of HIV in local residents every year, according to the "Status of the Local HIV/AIDS Epidemic" report issued by the county's Public Health office in January.
Ask D'Mine: Hepatitis and Diabetes, Going Low with the Flu
George from Wyoming, type 2, writes: I recently visited my doctor and she told me that I have get an immunization for hepatitis because I have diabetes.
Also on Topix